<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24424513</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>04</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>09</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2168-6211</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>168</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2014</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>JAMA pediatrics</Title>
<ISOAbbreviation>JAMA Pediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial.</ArticleTitle>
<Pagination>
<MedlinePgn>228-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapediatrics.2013.4367</ELocationID>
<Abstract>
<AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Infantile colic, gastroesophageal reflux, and constipation are the most common functional gastrointestinal disorders that lead to referral to a pediatrician during the first 6 months of life and are often responsible for hospitalization, feeding changes, use of drugs, parental anxiety, and loss of parental working days with relevant social consequences.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether oral supplementation with Lactobacillus reuteri DSM 17938 during the first 3 months of life can reduce the onset of colic, gastroesophageal reflux, and constipation in term newborns and thereby reduce the socioeconomic impact of these conditions.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">A prospective, multicenter, double-masked, placebo-controlled randomized clinical trial was performed on term newborns (age &lt;1 week) born at 9 different neonatal units in Italy between September 1, 2010, and October 30, 2012.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Parents were asked to record in a structured diary the number of episodes of regurgitation, duration of inconsolable crying (minutes per day), number of evacuations per day, number of visits to pediatricians, feeding changes, hospitalizations, visits to a pediatric emergency department for a perceived health emergency, pharmacologic interventions, and loss of parental working days.</AbstractText>
<AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">In total, 589 infants were randomly allocated to receive L reuteri DSM 17938 or placebo daily for 90 days.</AbstractText>
<AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Prophylactic use of probiotic.</AbstractText>
<AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">Reduction of daily crying time, regurgitation, and constipation during the first 3 months of life. Cost-benefit analysis of the probiotic supplementation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At 3 months of age, the mean duration of crying time (38 vs 71 minutes; P &lt; .01), the mean number of regurgitations per day (2.9 vs 4.6; P &lt; .01), and the mean number of evacuations per day (4.2 vs 3.6; P &lt; .01) for the L reuteri DSM 17938 and placebo groups, respectively, were significantly different. The use of L reuteri DSM 17938 resulted in an estimated mean savings per patient of €88 (US $118.71) for the family and an additional €104 (US $140.30) for the community.</AbstractText>
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Prophylactic use of L reuteri DSM 17938 during the first 3 months of life reduced the onset of functional gastrointestinal disorders and reduced private and public costs for the management of this condition.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">clinicaltrials.gov Identifier: NCT01235884.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Indrio</LastName>
<ForeName>Flavia</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Aldo Moro University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Di Mauro</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Aldo Moro University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Riezzo</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Experimental Physiopathology, National Institute for Digestive Diseases, IRCCS "Saverio de Bellis," Castellana Grotte, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Civardi</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Intini</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, Ospedale S.S. Annunziata, Taranto, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Corvaglia</LastName>
<ForeName>Luigi</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, S. Orsola-Malpighi University Hospital, Bologna, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ballardini</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, University of Ferrara, Ferrara, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bisceglia</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, San Giovanni di Dio Hospital, Crotone, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cinquetti</LastName>
<ForeName>Mauro</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Ospedale Fracastoro, San Bonifacio, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brazzoduro</LastName>
<ForeName>Emanuela</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Department of Pediatrics, Ospedale Sesto San Giovanni, Sesto San Giovanni, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Del Vecchio</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Neonatology, Di Venere Hospital, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tafuri</LastName>
<ForeName>Silvio</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Biomedical Sciences and Human Oncology, Section of Hygiene, Aldo Moro University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Francavilla</LastName>
<ForeName>Ruggiero</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Pediatrics, Aldo Moro University of Bari, Bari, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT01235884</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>JAMA Pediatr</MedlineTA>
<NlmUniqueID>101589544</NlmUniqueID>
<ISSNLinking>2168-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA Pediatr. 2014 Mar;168(3):204-5</RefSource>
<PMID Version="1">24424486</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA Pediatr. 2014 Aug;168(8):778</RefSource>
<PMID Version="1">25090301</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>J Pediatr. 2014 Jul;165(1):210</RefSource>
<PMID Version="1">24973164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>JAMA Pediatr. 2014 Aug;168(8):777-8</RefSource>
<PMID Version="1">25090299</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002908">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003085">Colic</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003248">Constipation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003362">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003448">Crying</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004311">Double-Blind Method</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005764">Gastroesophageal Reflux</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007231">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D052200">Lactobacillus reuteri</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019936">Probiotics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000191">economics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>1</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>1</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>4</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24424513</ArticleId>
<ArticleId IdType="pii">1812293</ArticleId>
<ArticleId IdType="doi">10.1001/jamapediatrics.2013.4367</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>